BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261005
DTEND;VALUE=DATE:20261009
DTSTAMP:20260609T080948Z
CREATED:20260608T204856Z
LAST-MODIFIED:20260609T080948Z
UID:10000756-1791158400-1791503999@oncodaily.com
SUMMARY:The 16th World Clinical Biomarkers and Companion Diagnostics Summit
DESCRIPTION:The landmark World Clinical Biomarkers & Companion Diagnostics Summit returns to Boston at a pivotal moment for precision medicine. With rapid advances in genomic testing\, companion diagnostics\, digital pathology\, spatial omics\, multimodal analytics\, and AI-enabled platforms\, the summit will bring together more than 850 senior stakeholders across biopharma\, diagnostics\, regulatory\, healthcare\, CRO\, testing lab\, and technology communities to accelerate drug-diagnostic innovation and improve patient access to precision care. \nEvent Name: 16th World Clinical Biomarkers & Companion Diagnostics Summit  \nEvent Date: October 5-8\, 2026 \nEvent Venue: The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA 02210 \nRecent regulatory shifts\, followed by a surge in Rx-Dx launches\, expanded access in advanced genomic testing\, rapid innovation in digital pathology\, spatial omics\, multimodal analytics and agentic AI diagnostic platforms\, alongside sustained\, sizeable investments\, signal that precision medicine is entering a defining new era. \nIt is in this context that the 16th World Clinical Biomarkers & Companion Diagnostics Summit returns to Boston\, as your longest-standing definitive forum uniting the complete precision medicine ecosystem. Boasting an audience of 850+ senior stakeholders from biopharma\, diagnostic\, regulatory\, healthcare\, CRO\, testing labs and multimodal communities\, this remains the place to strengthen and build the necessary collaborations to accelerate drug-diagnosti  innovations from bench to bedside. \nBe the first to see the newly released 4-day program. \nTo reflect the complex nature and rapid acceleration of novel endpoints and IVD advances\, this year’s meeting will expand to five dedicated content tracks. \n\nBiomarker Discovery & Translation: Equip your translation development\, biomarker discovery\, biomarker operations and oncology teams with the insights needed to validate novel\, highly translatable biomarker panels for both solid tissue and liquid biopsy diagnostic strategies.\nClinical & CDx Development: Aimed at clinical development\, medical affairs\, CDx development\, strategic partnerships and regulatory teams\, this content will provide you with the toolkit to deliver compliant clinical trials\, enrolment and monitoring workflows.\nRx-Dx Commercialization & Adoption: Provide your pricing\, reimbursement\, market access\, HOER and commercialization teams with access to the latest industry shifts and international payer evidence needs\, to ensure rapid synchonrised\, global adoption.\nDigital Pathology & Spatial Biomarkers: Designed for digital pathology\, imaging\, spatial biology and CDx development teams\, this new track will dive into best-in- class ways to standardize analysis\, boost throughput and improve reproducibility.\nMultimodal & AI-Enabled Precision Medicine: Offer your data science\, RWE\, AI & analytics and digital innovation teams\, the chance to hear the cutting-edge data driving and ML-enabled biomarker discovery\, clinical insights\, and precision endpoints.\n\nConvene with peers\, benchmark strategies\, forge new connections\, stay informed on the latest industry trends and streamline your co development pipeline\, at the industry’s leading touchpoint for precision medicine professionals. \nTogether let’s bring accessible\, affordable precision healthcare to patients quicker. \nAttendance is free* for drug developers and researchers. \n*Subject to eligibility and Ts and Cs: visit the website to learn more.
URL:https://oncodaily.com/event/16th-world-clinical-biomarkers-517593
LOCATION:The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA 02210\, The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/OncoDiaily.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261006
DTEND;VALUE=DATE:20261009
DTSTAMP:20251117T110913Z
CREATED:20251117T110848Z
LAST-MODIFIED:20251117T110913Z
UID:10000365-1791244800-1791503999@oncodaily.com
SUMMARY:EACR Conference on Cancer Metabolism
DESCRIPTION:The European Association for Cancer Research (EACR) Conference on Cancer Metabolism will be held in Bilbao\, Spain\, from October 6–8\, 2026. This conference focuses on metabolic reprogramming\, a key hallmark of tumors\, and the metabolic alterations that cancer and stromal cells undergo to meet energetic demands\, survive in hostile environments\, and modify their niche. \nThe meeting will gather top experts to discuss the mechanisms through which metabolites regulate cell decisions\, the metabolic interaction between the tumor and the host\, and explore undocumented metabolic alterations in cancer. It targets basic and translational scientists and clinicians\, aiming to provide a broad and detailed overview of the most recent advances in the field. \nRegister.
URL:https://oncodaily.com/event/eacr-411028
LOCATION:The Euskalduna Conference Centre\, Abandoibarra Etorb.\, 4\, Abando\, Bilbao\, Bizkaia\, 48011\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/WhatsApp-Image-2025-11-17-at-15.06.47.jpeg
ORGANIZER;CN="European Association for Cancer Research":MAILTO:jane.smith@eacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20261006T000000
DTEND;TZID=Europe/Paris:20261008T153000
DTSTAMP:20260221T093949Z
CREATED:20260221T093949Z
LAST-MODIFIED:20260221T093949Z
UID:10000657-1791244800-1791473400@oncodaily.com
SUMMARY:The Early Detection of Cancer Conference 2026
DESCRIPTION:The Early Detection of Cancer Conference 2026 is set to convene from October 6–8 at the Edinburgh International Conference Centre (EICC) in Scotland.  \nCo-hosted by Cancer Research UK and the OHSU Knight Cancer Institute\, this premier three-day summit serves as a global focal point for the International Alliance for Cancer Early Detection (ACED). \nThe program is designed to transcend traditional research presentations\, featuring high-stakes “Great Debates” and multidisciplinary panels that bridge the gap between discovery biology and clinical implementation. Bringing together a diverse community of scientists\, clinicians\, and industry leaders\, the 2026 meeting will prioritize the translation of cutting-edge technologies—including AI-driven diagnostics and multi-cancer early detection (MCED) tests—into equitable healthcare solutions aimed at identifying cancer at its most treatable stages.
URL:https://oncodaily.com/event/cancer-458938
LOCATION:Edinburgh International Conference Centre (EICC)\, 150 Morrison St\, Edinburgh\, EH3 8EE
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-21T134019.723.webp
ORGANIZER;CN="Cancer Research UK":MAILTO:supporter.services@cancer.org.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261006T180000
DTEND;TZID=America/Halifax:20261006T190000
DTSTAMP:20260724T121622Z
CREATED:20260724T121501Z
LAST-MODIFIED:20260724T121622Z
UID:10000819-1791309600-1791313200@oncodaily.com
SUMMARY:SPCC Webinar 2026: How Supportive Care Can Improve Cancer Survival
DESCRIPTION:The live webinar “Supportive Care Enhances Patient Survival”\, organized by Sharing Progress in Cancer Care (SPCC)\, will take place on 6 October 2026 from 18:00 to 19:00 CEST\, with CME accreditation in progress. \nThe session will explore how exercise\, nutrition\, symptom management\, and integrative oncology can improve quality of life\, treatment delivery\, and clinical outcomes for people with cancer. Julie Gralow will discuss the role of exercise in oncology\, while Andreas Charalambous will examine how integrating symptom management into cancer care may contribute to improved survival. Matti Aapro and Karim Nagui will co-chair the webinar\, which will also include a discussion\, Q&A\, and closing remarks. The session is part of the SPCC Corporate Programme on Integrative Oncology. \nLogin for the Webinar.
URL:https://oncodaily.com/event/spcc-webinar-2026-550038
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/spcc-e1731076868159-800x477-1-1.webp
ORGANIZER;CN="Sharing Progress in Cancer Care (SPCC)":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261010
DTSTAMP:20260720T151856Z
CREATED:20260720T151732Z
LAST-MODIFIED:20260720T151856Z
UID:10000804-1791417600-1791590399@oncodaily.com
SUMMARY:4th International Conference on Innovations and Advances in Cancer Research and Treatment - UICC
DESCRIPTION:The 4th International Conference\, on Innovations and Advances in Cancer Research and Treatment – Cancer 2026\, organized by Scitechseries\, will take place on 8–9 October 2026 at ANA Crowne Plaza Narita in Chiba\, Japan. \nUnder the theme “Empowering Global Collaboration in Cancer Care\,” the conference will bring together researchers\, oncologists\, geneticists\, engineers\, and other specialists to discuss advances in cancer research\, precision medicine\, emerging therapies\, and innovative technologies. The programme will include keynote lectures\, oral and poster presentations\, panel discussions\, and more than 20 thematic tracks. Accepted conference proceedings will be peer-reviewed and published in Archives in Oncology Research with DOI assignment. \n 
URL:https://oncodaily.com/event/4th-international-conference-on-innovations-546784
LOCATION:ANA Crowne Plaza Narita\, 68 Horinouchi\, Narita\, Chiba\, 286-0107\, Japan
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-20-2026-06_48_15-PM.webp
ORGANIZER;CN="Scitechseries":MAILTO:info@scitechseries.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261010
DTSTAMP:20260726T101122Z
CREATED:20260726T101122Z
LAST-MODIFIED:20260726T101122Z
UID:10000833-1791417600-1791590399@oncodaily.com
SUMMARY:Mammo 2026: Global Breast Cancer Virtual Congress
DESCRIPTION:The Mammo 2026 Global Breast Cancer Virtual Congress\, organized by OncoDaily\, will take place online on 8–9 October 2026. \nThe international congress will bring together leading breast cancer specialists to examine practical\, evidence-based approaches to screening\, early diagnosis\, risk stratification\, multidisciplinary treatment\, survivorship\, and the management of early-stage\, metastatic\, HER2-positive\, hormone receptor-positive\, and triple-negative breast cancer. \nKey topics will include antibody–drug conjugates\, endocrine therapy sequencing\, immunotherapy\, surgical de-escalation\, breast imaging\, cancer genetics\, circulating tumour DNA\, fertility preservation\, lifestyle interventions\, and precision oncology. Scientific leadership is provided by Giuseppe Curigliano\, Antonio Marra\, and Sara Tolaney. The programme is designed for medical\, surgical\, and radiation oncologists\, pathologists\, radiologists\, researchers\, and oncology trainees seeking a globally informed update on breast cancer care in 2026. \nRegister Now.
URL:https://oncodaily.com/event/mammo-2026-551235
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/IMG_7626-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261011
DTSTAMP:20260313T133638Z
CREATED:20260313T120435Z
LAST-MODIFIED:20260313T133638Z
UID:10000563-1791417600-1791676799@oncodaily.com
SUMMARY:2nd Australasian International Breast Congress (AIBC)
DESCRIPTION:The 2nd Australasian International Breast Congress (AIBC) will take place in Brisbane\, Australia\, from October 8–10\, 2026\, bringing together the Australasian Society for Breast Disease (ASBD)\, the World Congress on Controversies in Breast Cancer (CoBrCa)\, and Breast Surgeons of Australia and New Zealand (BreastSurgANZ) for a comprehensive joint meeting. \nThe congress will address the most controversial and practice-defining issues in breast disease and breast cancer care through expert presentations\, debates\, and interactive discussions\, complemented by workshops led by local and international experts. \nDesigned for a multidisciplinary audience—including oncologists\, surgeons\, radiologists\, pathologists\, nurses\, allied health professionals\, trainees\, and students—the meeting offers global networking opportunities and ample time for speaker–audience engagement after each session.
URL:https://oncodaily.com/event/aibc-437775
LOCATION:Brisbane Convention & Exhibition Centre\, Cnr Merivale and Glenelg Street\, South Banks\, Brisbane\, Queensland\, 4101\, Australia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/image-Picsart-AiImageEnhancer-1.webp
ORGANIZER;CN="World Congress on Controversies in Breast Cancer (CoBrCa)":MAILTO:cobrca@congressmed.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261009
DTEND;VALUE=DATE:20261010
DTSTAMP:20251102T221117Z
CREATED:20251102T221105Z
LAST-MODIFIED:20251102T221117Z
UID:10000309-1791504000-1791590399@oncodaily.com
SUMMARY:2026 NFCR Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship
DESCRIPTION:The 2026 NFCR Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship is a high-impact annual gathering hosted by the National Foundation for Cancer Research (NFCR) where science and entrepreneurship intersect to accelerate cancer breakthroughs. Scheduled for Friday\, October 9\, 2026\, this event is designed to spark powerful partnerships and collaborations among diverse leaders and advocates. The summit features a Scientific Symposium on new frontiers in cancer research\, a Leadership Forum focusing on biotech investment and industry direction\, and the prestigious Szent-Györgyi Prize Award Ceremony\, which honors scientists for their seminal discoveries in the field. \nYou can find more posts featuring NFCR on OncoDaily.
URL:https://oncodaily.com/event/nfcr-global-summit-402231
LOCATION:The National Press Club\, 529 14th St NW\, Washington\, 20045\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/NFCR-Global-Summit-Dateless-thumbnail.png
ORGANIZER;CN="National Foundation for Cancer Research":MAILTO:info@nfcr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261009
DTEND;VALUE=DATE:20261011
DTSTAMP:20260620T134216Z
CREATED:20260620T134216Z
LAST-MODIFIED:20260620T134216Z
UID:10000767-1791504000-1791676799@oncodaily.com
SUMMARY:European School of Oncology's Basics in Breast Cancer Surgery
DESCRIPTION:The European School of Oncology’s Basics in Breast Cancer Surgery course is a hybrid educational event consisting of pre-recorded online lectures available from 27 July 2026 and a hands-on\, practical training session taking place on either 9 or 10 October 2026 at Imperial College London\, UK. \nChaired by Riccardo A. Audisio (IT)\, the program offers an exhaustive insight into modern breast surgery\, focusing equally on cancer control\, cosmetic outcomes\, and disease biology. \nThe curriculum outlines technical details for thirteen distinct surgical procedures\, including sentinel node biopsies\, axillary dissection\, and the removal of non-palpable lesions. Utilizing custom-made mannequin models paired with personal mentor guidance\, this limited-enrolment course provides young surgical oncologists with the evidence-based strategies and hands-on skills required to optimize modern clinical practice.
URL:https://oncodaily.com/event/breast-cancer-524504
LOCATION:Imperial College London\, Exhibition Rd\, South Kensington\,\, London\, London SW7 2AZ
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/489925862_1013733717540434_6991574302178764021_n.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261009
DTEND;VALUE=DATE:20261011
DTSTAMP:20260725T115907Z
CREATED:20260725T115907Z
LAST-MODIFIED:20260725T115907Z
UID:10000825-1791504000-1791676799@oncodaily.com
SUMMARY:FLASCO Fall Oncology Congress 2026
DESCRIPTION:The FLASCO Fall Oncology Congress 2026\, organized by the Florida Society of Clinical Oncology (FLASCO) and sponsored or cosponsored by the American Society of Clinical Oncology (ASCO)\, will take place on 9–10 October 2026 at the Tampa Marriott Water Street in Tampa\, Florida. The congress will bring together oncology professionals for educational sessions and discussions focused on current developments in cancer care. \n 
URL:https://oncodaily.com/event/oncology-congress-550793
LOCATION:Tampa Marriott Water Street\, 505 Water Street\, Tampa\, FL\, 33602\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/2026-Fall-Congress-Save-The-Date.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261009
DTEND;VALUE=DATE:20261012
DTSTAMP:20260319T132806Z
CREATED:20260319T132806Z
LAST-MODIFIED:20260319T132806Z
UID:10000703-1791504000-1791763199@oncodaily.com
SUMMARY:IASO-NATCON 2026
DESCRIPTION:The IASO-NATCON 2026 (39th Annual Conference of the Indian Association of Surgical Oncology) is scheduled for October 9–11\, 2026\, in the culturally rich city of Lucknow\, with specialized workshops beginning on October 8. \nJointly organized by the IASO and the Lucknow Oncology Association (LOA)\, the conference is themed “Extending reach\, enhancing precision – Uniting Surgical Minds.” Attendees will engage in a high-level scientific program featuring keynote addresses from global experts\, hands-on workshops in robotic and minimally invasive surgery\, and sessions dedicated to precision oncology and multidisciplinary care. A major highlight of this edition is the IASO NATCON 2026 Golden Jubilee Awards\, offering over 50 cash prizes and the opportunity for selected abstracts to be published in the Indian Journal of Surgical Oncology (IJSO).
URL:https://oncodaily.com/event/iaso-natcon-2026-471459
LOCATION:Atal Bihari Vajpayee Medical University\, CG City\, Sultanpur Road\, Lucknow\, Uttar Pradesh\, 226002\, India
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/slide1-1.webp
ORGANIZER;CN="Indian Association of Surgical Oncology (IASO)":MAILTO:iasosecretariat@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261009T080000
DTEND;TZID=America/Halifax:20261009T080000
DTSTAMP:20260818T153641Z
CREATED:20260818T153641Z
LAST-MODIFIED:20260818T153641Z
UID:10000932-1791532800-1791532800@oncodaily.com
SUMMARY:Transforming Care for Medically Complex Children - NYU Langone Health
DESCRIPTION:The Transforming Care for Medically Complex Children: Addressing Developmental Challenges Through Multidisciplinary Interventions course\, organized by NYU Langone Health – Rusk Rehabilitation\, will take place on October 9\, 2026\, in New York City\, with both in-person attendance and a livestream option available. \nThe continuing education course is designed for healthcare professionals involved in the care of medically complex pediatric patients and will explore how coordinated\, multidisciplinary interventions can improve developmental outcomes by integrating medical\, rehabilitation\, developmental\, and family-centered approaches. \nThe course is directed by Megan Conklin\, Nicole Greene\, and Tina Tan\, and the in-person program will be held at NYU Langone Health\, Alumni Hall B\, 1st Floor\, 550 First Avenue. A networking event is also planned for in-person attendees at the conclusion of the course.
URL:https://oncodaily.com/event/nyu-langone-health-569438
LOCATION:NYU Langone Health – Alumni Hall B\, 1st Floor\, 550 First Avenue\, New York\, NY\, 10016\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-18-2026-07_25_37-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261009T130000
DTEND;TZID=America/Halifax:20261009T171500
DTSTAMP:20260815T155033Z
CREATED:20260815T155033Z
LAST-MODIFIED:20260815T155033Z
UID:10000915-1791550800-1791566100@oncodaily.com
SUMMARY:The 2nd National Day Against Cancer in Older Adults
DESCRIPTION:The 2nd National Day Against Cancer in Older Adults (Journée Nationale Contre les Cancers des Seniors)\, organized by the Société Francophone d’Onco-Gériatrie (SOFOG)\, will culminate in a national conference on 9 October 2026 at the Palais Bourbon in Paris\, France. \nThe event will bring together oncology and geriatrics specialists\, institutions\, patient organizations\, patients\, and caregivers to address key challenges at the intersection of cancer and aging\, including early detection\, equitable access to innovation\, shared decision-making\, and the patient–healthcare professional relationship. \nThe programme will feature expert discussions on tailoring oncogeriatric care to older patients\, a research session on defining appropriate treatment strategies\, and patient and caregiver perspectives on living with cancer. The conference will run from 1:00 PM to 5:15 PM\, followed by press exchanges and a closing reception\, while regional initiatives across France will extend the campaign beyond the national meeting.
URL:https://oncodaily.com/event/2nd-national-day-against-cancer-567047
LOCATION:Palais Bourbon – Assemblée nationale\, 126 Rue de l’Université\, Paris\, Île-de-France\, 75007\, France
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-15-2026-07_47_48-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261010T070000
DTEND;TZID=America/Halifax:20261010T210000
DTSTAMP:20260816T145040Z
CREATED:20260816T145040Z
LAST-MODIFIED:20260816T145040Z
UID:10000917-1791615600-1791666000@oncodaily.com
SUMMARY:D.C. Lung Cancer Conference 2026
DESCRIPTION:The D.C. Lung Cancer Conference 2026\, organized by MedStar Health\, will take place on 10 October 2026\, from 7:00 AM to 9:00 PM\, at the JW Marriott in Washington\, D.C. \nThe one-day multidisciplinary meeting will provide clinicians with a comprehensive update on recent advances across the lung cancer care continuum\, from screening and diagnosis to molecular testing and treatment. \nTopics will include CT screening\, liquid biopsy\, interpretation of biomarker testing\, smoking cessation\, minimally invasive surgery\, neoadjuvant and adjuvant systemic therapy\, immunotherapy\, targeted therapies for molecularly defined NSCLC\, advanced small cell lung cancer\, immune-mediated toxicities\, and rarer thoracic malignancies including thymic tumors and mesothelioma. \nSessions will feature international experts\, detailed case discussions\, frequent Q&A\, and an opening perspective from a patient advocate. The conference offers up to 7.0 continuing education credits\, and proceeds from the meeting will benefit the Lung Cancer Care Research Fund. Registration is $250 for physicians\, $195 for IASLC members\, free for residents/fellows\, $175 for several allied healthcare professional categories\, and $350 for industry professionals.
URL:https://oncodaily.com/event/lung-cancer-conference-567698
LOCATION:JW Marriott Washington\, DC\, 1331 Pennsylvania Avenue NW\, Washington\, DC\, 20004\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/1760372724127.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261010T080000
DTEND;TZID=America/Halifax:20261010T163000
DTSTAMP:20260730T175339Z
CREATED:20260730T175339Z
LAST-MODIFIED:20260730T175339Z
UID:10000848-1791619200-1791649800@oncodaily.com
SUMMARY:2026 Pacific Northwest Head and Neck Cancer Symposium
DESCRIPTION:The 2026 Pacific Northwest Head & Neck Cancer Symposium: Updates in the Management of Head and Neck Cancer\, hosted by Fred Hutch Cancer Center\, will take place on 10 October 2026\, from 8:00 a.m. to 4:30 p.m. PT\, at the Arnold Building’s Behnke Suites in Seattle\, Washington. \nThis in-person multidisciplinary programme will provide evidence-based updates on neoadjuvant and adjuvant immunotherapy\, salivary gland cancers\, proton and neutron radiotherapy\, well-differentiated and anaplastic thyroid cancers\, and innovations in surgical ablation and reconstruction. It will also address implicit bias in head and neck cancer diagnosis and care.
URL:https://oncodaily.com/event/head-and-neck-cancer-symposium-555375
LOCATION:Arnold Building – Behnke Suites\, 1100 Fairview Avenue North\, Seattle\, WA\, 98109\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-30-2026-09_52_07-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261011
DTEND;VALUE=DATE:20261014
DTSTAMP:20260609T101350Z
CREATED:20260609T101350Z
LAST-MODIFIED:20260609T101350Z
UID:10000757-1791676800-1791935999@oncodaily.com
SUMMARY:13th International Paediatric Renal Tumours Biology Conference\, London\, 11-13th October 2026
DESCRIPTION:The 13th International Paediatric Renal Tumours Biology Conference is scheduled to take place from October 11 to October 13\, 2026\, at the Francis Crick Institute in London.  \nHosted by the UK Renal Tumour Umbrella Plus team\, this specialized biennial forum is organized in close collaboration with the International Society of Paediatric Oncology Renal Tumour Study Group (SIOP-RTSG) and the North American Children’s Oncology Group’s Renal Tumour Committee (COG-RTC).  \nLed locally by Dr. Tanzina Chowdhury\, Professor Sam Behjati\, Dr. Jonny Kennedy\, and Ms. Reem Al-Saadi\, the three-day program stands as the only global meeting dedicated exclusively to childhood kidney cancer biology. The event bridges basic science\, translational research\, and clinical trial design through expert keynotes on liquid biopsy and developmental therapeutics\, a foundational educational session\, and interactive workshops aimed at driving the next generation of international collaborative treatment protocols. \nDeadline for abstract submission is 12th June\, 2026\, 10pm CET.
URL:https://oncodaily.com/event/renal-tumours-517756
LOCATION:Francis Crick Institute\, 1 Midland Rd\, London\, NW1 1AT\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/BeFunky-collage-2026-06-09T140501.065.webp
ORGANIZER;CN="International Society of Paediatric Oncology (SIOP)":MAILTO:info@siop-online.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261013
DTEND;VALUE=DATE:20261014
DTSTAMP:20260725T143646Z
CREATED:20260725T143646Z
LAST-MODIFIED:20260725T143646Z
UID:10000828-1791849600-1791935999@oncodaily.com
SUMMARY:The Iowa Cancer Summit 2026
DESCRIPTION:The Iowa Cancer Summit 2026\, organized by the Iowa Cancer Consortium\, will take place on 13 October 2026 at the FFA Enrichment Center in Ankeny\, Iowa. \nAs the state’s comprehensive cancer control conference\, the Summit will bring together healthcare professionals\, researchers\, patient advocates\, and community leaders to exchange promising practices and strengthen collaboration across cancer prevention\, screening\, treatment\, survivorship\, and health equity. Registration is expected to open in August 2026. Sponsorship and exhibition opportunities are also available for organisations seeking to connect with cancer control leaders from across Iowa.
URL:https://oncodaily.com/event/iowa-cancer-summit-550946
LOCATION:FFA Enrichment Center\, 1055 SW Prairie Trail Parkway\, Ankeny\, IA\, 50023\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-25-2026-06_35_58-PM.webp
ORGANIZER;CN="Iowa Cancer Consortium":MAILTO:staff@canceriowa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261013
DTEND;VALUE=DATE:20261016
DTSTAMP:20260120T131757Z
CREATED:20260120T131743Z
LAST-MODIFIED:20260120T131757Z
UID:10000601-1791849600-1792108799@oncodaily.com
SUMMARY:DMM26: Innovative Preclinical Models for Pediatric Cancer Research
DESCRIPTION:The conference “Innovative Preclinical Models for Pediatric Cancer Research” (DMM26) is a specialized scientific meeting scheduled for October 13–15\, 2026. \nOrganized by the Company of Biologists\, this event focuses on the development and application of advanced models – including organoids\, PDX models\, and CRISPR-engineered systems – to better understand childhood cancers and accelerate drug discovery. The program features world-renowned experts such as Caroline Hutter\, Martine Roussel\, and Sam Behjati\, and emphasizes cross-disciplinary collaboration between basic scientists and clinicians to address the unique challenges of pediatric oncology.
URL:https://oncodaily.com/event/dmm26-444061
LOCATION:Nationwide Children’s Hospital Conference Center\, 520 Butterfly Gardens Dr\, Columbus\, OH\, 43215\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/DMM26.webp
ORGANIZER;CN="Company of Biologists":MAILTO:subscriptions@biologists.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261014
DTEND;VALUE=DATE:20261017
DTSTAMP:20260626T130921Z
CREATED:20260626T130921Z
LAST-MODIFIED:20260626T130921Z
UID:10000774-1791936000-1792195199@oncodaily.com
SUMMARY:Momentum 2026: Accelerating Europe’s Action On Cancer
DESCRIPTION:Taking place 14–16 October at Artipelag\, Stockholm\, Momentum is a high-level summit convened by the CancerFonden – Swedish Cancer Society\, bringing together a carefully curated group of leaders from across sectors — policymakers\, healthcare leaders\, patient representatives\, researchers\, industry and investors — with a shared ambition: to accelerate Europe’s action on cancer. \nAcross Europe\, world-class cancer research discoveries are being made\, yet too often they take too long to reach patients. The gap between research\, decision-making\, and real-world impact remains one of our greatest missed opportunities. Through roundtable discussions and co-creation sessions\, participants engage directly with the barriers holding progress back and contribute to shaping solutions\, with key issues including funding\, regulation\, data\, clinical trials and the uptake of innovation on the agenda. \n\nEarly sign-up deadline: 30 June \nFinal registration deadline: 17 August\n\nRegister now.
URL:https://oncodaily.com/event/momentum-528822
LOCATION:Artipelag\, Artipelagstigen 1\, Gustavsberg\, 134 40\, Sweden
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/13cb42522318482080c7ef5a6fdda0e7.webp
ORGANIZER;CN="Cancerfonden - The Swedish Cancer Society":MAILTO:info@cancerfonden.se
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261014
DTEND;VALUE=DATE:20261018
DTSTAMP:20260609T115610Z
CREATED:20260609T115610Z
LAST-MODIFIED:20260609T115610Z
UID:10000758-1791936000-1792281599@oncodaily.com
SUMMARY:22nd Biennial Meeting of the European Society for Immunodeficiencies (ESID 2026)
DESCRIPTION:The 22nd Biennial Meeting of the European Society for Immunodeficiencies (ESID 2026) will take place from October 14 to October 17\, 2026\, at the Maastricht Exhibition and Conference Centre (MECC) in Maastricht\, The Netherlands. \nOrganized by Kenes Group in conjunction with INGID and IPOPI\, this premier international forum is themed “Translational Immunology Beyond Boundaries.” Led by meeting chair Dr. Mirjam van der Burg and ESID president Dr. Fabio Candotti\, the four-day event bridges basic science\, diagnostics\, and patient care\, gathering researchers\, clinicians\, nurses\, and advocates to discuss breakthrough therapies for primary immunodeficiencies and inborn errors of immunity.
URL:https://oncodaily.com/event/esid-2026-517760
LOCATION:Maastricht Exhibition and Conference Centre\, Forum 100\, Maastricht\, 6229 GV\, Netherlands
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/c4f68f09f5ec472db809a8b7c1a3e44e.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261015
DTEND;VALUE=DATE:20261016
DTSTAMP:20260818T114111Z
CREATED:20260818T114111Z
LAST-MODIFIED:20260818T114111Z
UID:10000928-1792022400-1792108799@oncodaily.com
SUMMARY:Advancing Pediatric Liver Tumor Care: Bridging Global Standards and Asia-Pacific Practice
DESCRIPTION:The Advancing Pediatric Liver Tumor Care: Bridging Global Standards and Asia-Pacific Practice webinar\, organized by the International Society of Paediatric Oncology (SIOP)\, will take place on 15 October 2026. \nThe educational session will focus on current standards and future directions in pediatric liver tumor care\, with perspectives from the United States\, Japan\, Australia\, and the wider Asia-Pacific region. Topics include global advances in pediatric liver tumors\, pediatric liver tumor surgery in Japan\, and implementation of the ARIA framework in pediatric liver tumor care. The webinar is open to SIOP members and requires SIOP login credentials for registration.
URL:https://oncodaily.com/event/pediatric-liver-tumor-569102
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/IMG_2536-800x796-1.webp
ORGANIZER;CN="International Society of Paediatric Oncology (SIOP)":MAILTO:info@siop-online.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261015
DTEND;VALUE=DATE:20261017
DTSTAMP:20260702T104237Z
CREATED:20260702T104237Z
LAST-MODIFIED:20260702T104237Z
UID:10000783-1792022400-1792195199@oncodaily.com
SUMMARY:ESSO Advanced Course on the Treatment of Peritoneal Surface Malignancy
DESCRIPTION:The ESSO Advanced Course on the Treatment of Peritoneal Surface Malignancy takes place 15–16 October 2026 in Barcelona\, Spain.  \nThis comprehensive two-day workshop addresses the state-of-the-art multimodal treatment of peritoneal surface malignancies through plenary lectures\, MDT case sessions\, small group multilingual discussions\, video-based education\, and live surgery. \nDay 1 is held at Centro Médico Teknon and Day 2 at Hospital de Sant Joan Despí Moisès Broggi. Led by internationally renowned experts\, the programme covers patient selection\, the value of cytoreductive surgery across different disease types\, intraperitoneal chemotherapy including HIPEC and PIPAC\, morbidity and mortality reduction\, and neoadjuvant therapy strategies. The course is designed for teams of surgeons\, gynaecologic oncologists\, oncologists\, and nurse specialists already involved in or considering starting a peritoneal surface malignancy programme.
URL:https://oncodaily.com/event/peritoneal-surface-malignancy-533371
LOCATION:Centro Médico Teknon\, Carrer de Vilana 12\, Barcelona\, 08022\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/8e05ddb608734cc0beff48168ff7a668.webp
ORGANIZER;CN="European Society of Surgical Oncology":MAILTO:info@essoweb.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261015
DTEND;VALUE=DATE:20261017
DTSTAMP:20260719T164457Z
CREATED:20260719T164457Z
LAST-MODIFIED:20260719T164457Z
UID:10000794-1792022400-1792195199@oncodaily.com
SUMMARY:ESSO Hands-on Course on Minimally Invasive Oesophagectomy and Gastrectomy
DESCRIPTION:The Level 2 Hands-on Course on Minimally Invasive Oesophagectomy and Gastrectomy\, organized by the European Society of Surgical Oncology (ESSO)\, will take place on 15–16 October 2026 at University Medical Centre Utrecht\, The Netherlands. \nLed by an international faculty\, the course will combine expert lectures\, anatomy sessions\, live surgical demonstrations\, and hands-on cadaveric training. Participants will explore minimally invasive and robotic techniques\, common pitfalls\, and practical guidance for introducing these procedures in their own centres. The course is intended for surgeons with experience in minimally invasive surgery who wish to strengthen their upper gastrointestinal surgical practice. Applications are now closed\, with results to be announced by 15 July 2026. \nBecome a member.
URL:https://oncodaily.com/event/oesophagectomy-and-gastrectomy-545062
LOCATION:University Medical Centre Utrecht\, Heidelberglaan 100\, Utrecht\, Utrecht\, 3584 CX\, Netherlands
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-19-2026-08_43_27-PM.webp
ORGANIZER;CN="European Society of Surgical Oncology":MAILTO:info@essoweb.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261015
DTEND;VALUE=DATE:20261017
DTSTAMP:20260804T171527Z
CREATED:20260804T171404Z
LAST-MODIFIED:20260804T171527Z
UID:10000863-1792022400-1792195199@oncodaily.com
SUMMARY:28th Annual Blood-Brain Barrier Consortium
DESCRIPTION:The 28th Annual Blood-Brain Barrier Consortium Meeting\, hosted by the Providence Neuroscience Institute\, will take place in person on 15–16 October 2026\, from 8:00 a.m. to 5:00 p.m. PST\, at The Benson Hotel in Portland\, Oregon. \nThe programme will highlight advances in blood-brain barrier and neurovascular unit research\, including therapeutic delivery to brain tumours\, focused ultrasound\, intra-arterial treatments\, neuroinfectious disease\, neuroimmunology\, neuroimaging\, cognitive science\, and emerging health challenges such as microplastics\, climate change\, and space exploration. \nScientific sessions\, panels\, posters\, mentoring\, networking\, CME credits\, meals\, and recorded presentations are included. Abstracts and posters are due 3 August 2026\, while registration closes 13 October 2026. The registration fee was not provided; the optional keynote dinner costs $70\, and discounted hotel rooms start at $179 per night.
URL:https://oncodaily.com/event/blood-brain-barrier-559284
LOCATION:The Benson Hotel\, 309 SW Broadway\, Portland\, OR\, 97205\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-4-2026-09_12_56-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261015
DTEND;VALUE=DATE:20261017
DTSTAMP:20260815T152140Z
CREATED:20260815T144608Z
LAST-MODIFIED:20260815T152140Z
UID:10000913-1792022400-1792195199@oncodaily.com
SUMMARY:The 17th AFSOS National Congress of Supportive Oncology Care
DESCRIPTION:The 17th AFSOS National Congress of Supportive Oncology Care (Congrès National des Soins Oncologiques de Support)\, organized by the Association Francophone des Soins Oncologiques de Support (AFSOS)\, will take place on 15–16 October 2026 at Lille Grand Palais in Lille\, France\, following the 16th JR-SOS on 14 October. \nThe multidisciplinary meeting is designed for healthcare professionals involved in oncology and supportive cancer care and will focus on how rapidly evolving cancer treatments are reshaping supportive-care practice. \nA major scientific theme for 2026 is antibody–drug conjugates (ADCs)\, with three plenary sessions addressing their real-world value\, gastrointestinal\, pulmonary\, ocular and cutaneous toxicities\, and potential long-term effects. \nThe programme will also feature plenary lectures\, parallel sessions\, posters and industry exchanges covering artificial intelligence and digital tools\, disability and cancer care\, thrombocytopenia\, neutropenia\, financial toxicity\, nutrition\, prehabilitation\, palliative care\, photobiomodulation\, and adolescent and young adult oncology. Updated AFSOS recommendations on fertility\, mucositis and radiation-induced gynecologic adverse effects will also be presented.
URL:https://oncodaily.com/event/afsos-national-congress-566994
LOCATION:Lille Grand Palais\, 1 Boulevard des Cités Unies\, Lille\, Hauts-de-France\, 59777\, France
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-15-2026-07_19_55-PM.webp
ORGANIZER;CN="Association Francophone des Soins Oncologiques de Support (AFSOS)":MAILTO:info@comm-sante.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261015
DTEND;VALUE=DATE:20261019
DTSTAMP:20260806T152443Z
CREATED:20260806T152321Z
LAST-MODIFIED:20260806T152443Z
UID:10000878-1792022400-1792367999@oncodaily.com
SUMMARY:JADPRO Live 2026
DESCRIPTION:JADPRO Live 2026\, organized by Conexiant in collaboration with the Advanced Practitioner Society for Hematology and Oncology (APSHO)\, will take place on 15–18 October 2026 at the Minneapolis Convention Center in Minneapolis\, Minnesota\, with both in-person and virtual participation available. \nRecognized as a leading CE-accredited meeting for oncology advanced practitioners\, the conference is expected to welcome more than 1\,600 attendees and feature over 30 educational sessions\, 50 exhibitors and sponsors\, and more than 25 CME/CE credit hours. The programme will address topics including multidisciplinary management of ER-positive breast cancer\, classical hematology consultations\, bispecific antibodies versus CAR T-cell therapy\, development of advanced practitioner-led clinics\, and difficult patient conversations. \nParticipants can also attend expert presentations\, poster and exhibit hall activities\, small-group discussions\, networking events\, and knowledge-sharing Braindates. Selected sessions will be available on demand from 28 October through 31 December 2026. \nRegister Now.
URL:https://oncodaily.com/event/jadpro-560920
LOCATION:Minneapolis Convention Center\, 1301 Second Avenue South\, Minneapolis\, MN\, 55403\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-6-2026-07_21_57-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261016
DTEND;VALUE=DATE:20261018
DTSTAMP:20251124T211146Z
CREATED:20251124T211131Z
LAST-MODIFIED:20251124T211146Z
UID:10000397-1792108800-1792281599@oncodaily.com
SUMMARY:ASCO Quality Care Symposium 2026
DESCRIPTION:The ASCO Quality Care Symposium 2026 is a hybrid medical conference dedicated to advancing the quality of cancer care. \nThe meeting will be held from October 16–17\, 2026\, both in-person at the Hynes Convention Center in Boston\, MA\, and online. The symposium focuses on sharing research\, innovations\, and practical strategies for improving patient outcomes\, healthcare value\, and the patient experience across the oncology continuum.
URL:https://oncodaily.com/event/asco-415813
LOCATION:John B. Hynes Veterans Memorial Convention Center\, 900 Boylston Street\, Boston\, MA\, 02115\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/image-6.webp
ORGANIZER;CN="American Society of Clinical Oncology":MAILTO:https://asco.org/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261016T075500
DTEND;TZID=America/Halifax:20261016T150000
DTSTAMP:20260804T175736Z
CREATED:20260804T175653Z
LAST-MODIFIED:20260804T175736Z
UID:10000866-1792137300-1792162800@oncodaily.com
SUMMARY:Benign Hematology and Thrombosis: 2026 Emerging Therapies - MSK
DESCRIPTION:The State of the Art in Benign Hematology\, Hemostasis\, and Thrombosis: 2026 Update in Emerging Therapeutics symposium\, hosted by Memorial Sloan Kettering Cancer Center (MSK)\, will take place in person on 16 October 2026\, from 7:55 a.m. to 3:00 p.m.\, at the Zuckerman Research Center in New York City. \nThe one-day programme will review current and emerging approaches to venous thromboembolism\, pulmonary embolism\, myeloma-associated thrombosis\, factor XI inhibitors\, venous stenting\, post-thrombotic syndrome\, cancer therapy-related cytopenias\, thrombopoietin receptor agonists\, hemophagocytic lymphohistiocytosis\, and immune thrombocytopenia. \nDesigned for hematologists\, oncologists\, advanced practice providers\, trainees\, nurses\, and other healthcare professionals\, the symposium will feature expert presentations\, interactive discussion\, and practical clinical cases. Early registration through 4 September 2026 ranges from $50 to $250\, while general rates range from $100 to $525\, depending on participant category.
URL:https://oncodaily.com/event/benign-hematology-559364
LOCATION:Mortimer B. Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-4-2026-09_55_44-PM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261017T080000
DTEND;TZID=America/Halifax:20261017T150000
DTSTAMP:20260730T155136Z
CREATED:20260730T155136Z
LAST-MODIFIED:20260730T155136Z
UID:10000842-1792224000-1792249200@oncodaily.com
SUMMARY:2026 WAHO and WON Advancing Oncology Together
DESCRIPTION:The 2026 WAHO and WON Advancing Oncology Together meeting\, organized by the Wisconsin Association of Hematology and Oncology (WAHO) and the Wisconsin Oncology Network (WON)\, will take place in person on 17 October 2026 from 8:00 a.m. to 3:00 p.m. CDT at the Madison Marriott West in Middleton\, Wisconsin. \nThe event will bring together oncology professionals from across the state to discuss emerging treatments\, local healthcare disparities\, practice-management challenges\, and collaborative strategies for improving cancer care. It is intended for physicians and multidisciplinary oncology professionals\, including nurses\, pharmacists\, physician assistants\, social workers\, administrators\, fellows\, and retirees. (waho-oncology.org)
URL:https://oncodaily.com/event/advancing-oncology-together-555198
LOCATION:Madison Marriott West\, 1313 John Q. Hammons Drive\, Middleton\, WI\, 53562\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/299e65796452da2e2811ddc41a9995545b9f0402-1607x1033-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261018
DTEND;VALUE=DATE:20261022
DTSTAMP:20260722T133915Z
CREATED:20260722T133717Z
LAST-MODIFIED:20260722T133915Z
UID:10000815-1792281600-1792627199@oncodaily.com
SUMMARY:19th AACR Conference on The Science of Cancer Health Disparities
DESCRIPTION:Organized by the American Association for Cancer Research (AACR) in association with the AACR Minorities in Cancer Research Council\, the 19th AACR Conference on the Science of Cancer Health Disparities will take place on 18–21 October 2026 at Hilton Atlanta in Atlanta\, Georgia. \nThe conference will bring together experts in basic\, translational\, clinical\, population\, behavioral\, computational\, and community-based research to address cancer disparities affecting vulnerable communities. Participants will share new findings\, exchange ideas\, and build collaborations aimed at advancing equitable cancer prevention\, treatment\, and outcomes. The abstract submission deadline is 23 July 2026 at 1:00 p.m. ET\, and the advance registration deadline is 8 September 2026. \nRegister Now.
URL:https://oncodaily.com/event/cancer-health-disparities-548684
LOCATION:Hilton Atlanta\, 255 Courtland Street NE\, Atlanta\, GA\, 30303\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/HNr8N37WcAAsf9X.webp
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
END:VCALENDAR